These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24291836)

  • 1. [Positron emission tomography in neurological disorders].
    Ishii K
    Rinsho Shinkeigaku; 2013; 53(11):930. PubMed ID: 24291836
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography applications in clinical neurology.
    Singhal T
    Semin Neurol; 2012 Sep; 32(4):421-31. PubMed ID: 23361486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography in neuroscience. An integrative part of clinical diagnostic methods and experimental research].
    Schaller B
    Radiologe; 2005 Feb; 45(2):186, 188-96. PubMed ID: 15662519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography imaging.
    Dhawan V; Eidelberg D
    Front Neurol Neurosci; 2009; 25():197-202. PubMed ID: 19478523
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography imaging in human immunodeficiency virus-1-associated neurocognitive disorders: an interesting case and a review of the positron emission tomography literature.
    Meyer PT; Gobbelé R; Ludolph A; Schaefer WM; Waberski TD; Schiel M
    Clin Nucl Med; 2009 Aug; 34(8):496-9. PubMed ID: 19617724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for modeling pathophysiological processes in vivo.
    Hendrikse NH; Luurtsema G; van der Veldt AA; Lubberink M
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):717-25. PubMed ID: 18729023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Role of PET in Pediatric Disorders.
    Zhuang H; Alavi A
    PET Clin; 2020 Jul; 15(3):xv-xvii. PubMed ID: 32498993
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional ultrasound neuroimaging: a review of the preclinical and clinical state of the art.
    Deffieux T; Demene C; Pernot M; Tanter M
    Curr Opin Neurobiol; 2018 Jun; 50():128-135. PubMed ID: 29477979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging in neurological disorders.
    Politis M; Piccini P
    J Neurol; 2012 Sep; 259(9):1769-80. PubMed ID: 22297461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET molecular imaging in stem cell therapy for neurological diseases.
    Wang J; Tian M; Zhang H
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1926-38. PubMed ID: 21698414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders].
    Momose T
    Brain Nerve; 2007 May; 59(5):495-501. PubMed ID: 17533975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Twelve years' clinical experience in using positron emission tomography: advances and prospects].
    Granov AM; Tiutin LA; Kostenikov NA; Shtukovskiĭ OA; Mostova MI; Ryzhkova DV; Tlostanova MS; Stanzhevskiĭ AA; Balabanova AA; Panfilenko AA
    Vestn Rentgenol Radiol; 2008; (1):10-8. PubMed ID: 22187894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural correlates of 'functional' symptoms in neurology.
    Montoya A; Price BH; Lepage M
    Funct Neurol; 2006; 21(4):193-7. PubMed ID: 17367578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of positron emission tomography.
    Watson JD
    Br J Hosp Med; 1991 Sep; 46(3):163-6. PubMed ID: 1933099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional neurological disorders: mechanisms and treatment.
    Lehn A; Gelauff J; Hoeritzauer I; Ludwig L; McWhirter L; Williams S; Gardiner P; Carson A; Stone J
    J Neurol; 2016 Mar; 263(3):611-20. PubMed ID: 26410744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
    Hesse S; Barthel H; Schwarz J; Sabri O; Müller U
    Neurosci Biobehav Rev; 2004 Oct; 28(6):547-63. PubMed ID: 15527862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives.
    Olivas Arroyo C
    Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hemiplegic migraine: permanent attack-related neurologic deficits.
    Dodick D; Roarke M
    Headache; 2007 Sep; 47(8):1210-2. PubMed ID: 17883529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Grid-based SPM service (GriSPM) for SPECT and PET neurological studies.
    Castiglioni I; Canesi B; Schenone A; Perani D; Gilardi MC
    Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1193-5. PubMed ID: 19440707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.